Bank of America
LMNL

Bank of America’s Liminal BioSciences Inc. Common Shares LMNL Stock Holding History

Bank of America’s Portfolio LMNL Stock Details LMNL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-140
Closed -$1K – 8606
2022
Q1 		$1K Buy
140
+130
+1,300% +$1.22K ﹤0.01% 8166
2021
Q4 		$0 Hold
10
– – ﹤0.01% 8835
2021
Q3 		$0 Hold
10
– – ﹤0.01% 8517
2021
Q2 		$0 Buy
+10
New +$436 ﹤0.01% 8230
2020
Q3 		– Sell
-13
Closed -$1K – 7282
2020
Q2 		$1K Buy
+13
New +$1.15K ﹤0.01% 6768
2020
Q1 		– Sell
-11
Closed -$1K – 7375
2019
Q4 		$1K Buy
+11
New +$742 ﹤0.01% 7002

Other funds holding LMNL

National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America's LMNL Position: Q2 2022 in Review

Bank of America sold out of Liminal BioSciences Inc. Common Shares (LMNL) in Q2 2022, closing a stake of 140 shares — an estimated $1K sold.

Bank of America first reported a position in LMNL in Q4 2019 and held it in 6 quarters. The position peaked at $1K in Q1 2022. 19 funds tracked by Wall St. Rank hold LMNL as of Q2 2022.

  • Bank of America reported no remaining Liminal BioSciences Inc. Common Shares position as of Q2 2022 after selling out during the quarter.
  • Bank of America sold 140 Liminal BioSciences Inc. Common Shares shares in Q2 2022, an estimated $1K.
  • Bank of America first reported a position in Liminal BioSciences Inc. Common Shares in Q4 2019 and held it in 6 quarters.
  • Bank of America's Liminal BioSciences Inc. Common Shares position peaked at $1K in Q1 2022.
  • 19 funds tracked by Wall St. Rank held Liminal BioSciences Inc. Common Shares as of Q2 2022.

Based on Bank of America's 13F filing for Q2 2022, filed 12 Aug 2022.